Back to Search
Start Over
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
- Source :
- Journal of Infectious Diseases; Dec2023, Vol. 228 Issue 12, p1662-1666, 5p
- Publication Year :
- 2023
-
Abstract
- We compared the serologic responses of 1 dose versus 2 doses of a variant vaccine (Moderna mRNA-1273 Beta/Omicron BA.1 bivalent vaccine) in adults. A 2-dose boosting regimen with a variant vaccine did not increase the magnitude or the durability of the serological responses compared to a single variant vaccine boost. [ABSTRACT FROM AUTHOR]
- Subjects :
- CLINICAL trials
SARS-CoV-2 Omicron variant
IMMUNE response
VACCINES
MESSENGER RNA
Subjects
Details
- Language :
- English
- ISSN :
- 00221899
- Volume :
- 228
- Issue :
- 12
- Database :
- Complementary Index
- Journal :
- Journal of Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 174386514
- Full Text :
- https://doi.org/10.1093/infdis/jiad323